Risperdal Trial Recap

risperdal trial

The antipsychotic drug Risperdal can cause devastating side effects in children, most notably gynecomastia in boys or the growth of breast tissue. In some cases, breast growth is so severe that patients must undergo invasive surgery to remove excess tissue. Risperdal manufacturer, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), faces thousands of lawsuits alleging it failed to warn patients of the risk of developing gynecomastia; and, several notable trials have paved the way for the Risperdal litigation.

What Is Risperdal?

Risperdal is an atypical antipsychotic drug used to treat bipolar disorder and schizophrenia in adults and adolescents. Risperdal affects the levels of dopamine and serotonin in the brain, neurotransmitters known to impact mood and behavior.

Risperdal Trials

By the time a Philadelphia jury decided the first Risperdal trial, Janssen and J&J had already paid out massive amounts to the both the government and individuals to settle claims of illegal marketing and that the company minimized the risk of gynecomastia. The plaintiff in that first trial began taking Risperdal when he was eight years old to treat symptoms of autism and developed substantial breast tissue as a result. In February 2015, the jury awarded him $2.5 million for J&J and Janssen’s negligence.

The second Risperdal trial occurred just one month later, and again a jury found J&J and Janssen guilty of illegally marketing Risperdal to children.

The third and fourth Risperdal trials were significant because both plaintiffs had taken Risperdal after it was approved for use in children. In both trials, the juries found J&J and Janssen were negligent in failing to warn patients of the risk of gynecomastia and awarded the third plaintiff $500,000 in December 2015 and the fourth plaintiff $1.75 million in November 2015.

The fifth and most recent Risperdal trial saw the largest damage award so far in the litigation. The trial, which concluded this past July, awarded the plaintiff $70 million.

Raizner Slania: Risperdal Attorneys

Raizner Slania is experienced in handling pharmaceutical lawsuits from start to finish, and will work with you each step of the way. Our pharmaceutical attorneys have been leaders in important nationwide litigation against large and powerful drug companies. If someone in your family has experienced physical and emotional trauma from taking Risperdal, please contact the attorneys at Raizner Slania LLP today for a free and confidential consultation to discuss your case.